Latest Articles and Analysis

Declining vaccination rates and policy challenges create vulnerability to vaccine-preventable diseases and epidemic risk.

Proposed Medicaid cuts and work requirements threaten coverage for millions including people living with HIV.

Q1 2025 Watch: comprehensive update on HIV/HCV co-infection treatment access across federal and state programs.

Insurance companies deploy AI algorithms for automated prior authorization denials, restricting patient access to prescribed treatments.

Pugh reflects on 340B policy and patient advocacy in ensuring equitable medication access.

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.

Proposed Cigna-Humana merger implications for healthcare competition and access.

Federal policy failures on copay accumulator programs restrict patient assistance benefits.

Medicaid disenrollment during pandemic unwinding and impacts on vulnerable populations.

Barriers to PrEP access for minors in Southern states: legal and political obstacles.

Grindr's at-home STI testing kits address barriers to sexual health testing.

Q3 2024 Watch monitoring HCV treatment access across ADAPs, Medicaid, Veterans programs, and assistance initiatives.

First year results of Together TakeMeHome HIV self-testing distribution program.

Potential harms of state PDABs on HIV treatment access and ending the epidemic.

Unintended consequences of Inflation Reduction Act drug pricing provisions.

CDC doxycycline post-exposure prophylaxis guidance for STI prevention amid political debate.

Analysis of ADA protections for PLWHA including workplace discrimination and HIV criminalization.

Barriers to HIV care for formerly incarcerated people and continuity strategies.

Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.

How payor cost-containment strategies drive health disparities and limit care access.